Beta-Casein Based Nano-Vehicles for Oral Delivery of Chemotherapeutic Drugs: Drug-Protein Interactions and Mitoxantrone Loading Capacity
Received 23 July 2009; received in revised form 27 December 2009; accepted 19 January 2010. published online 25 January 2010. Accepted Manuscript
Abstract
Beta-casein (β-CN), a major milk protein, is amphiphilic and self-associates into micelles in aqueous solutions. We have recently introduced (Shapira A. et al, Nanomedicine 2009 (in press)) a novel oral drug delivery system based on β-CN nanoparticles. The current research builds up and complements this work by studying the interactions of mitoxantrone (MX) and β-CN as they co-assemble into nanoparticles, using absorption and emission spectra, static and dynamic light scattering and by fluorescent emission of both MX and Trp-143 of β-CN. The optimal loading molar-ratio was 3.3 MX:β-CN at 1mg/ml β-CN and the association constant was (2.45±1.76)x105M-1 based on β-CN Trp143 fluorescence; independent MX fluorescence results provided supporting values. In these conditions a bimodal particle distribution was obtained (174.4 nm, 45.9%; 485.1 nm, 54.1%). The gastric digestibility of β-CN suggests possible targeting to stomach tumors. Hence, β-CN nanoparticles may serve as effective vehicles of hydrophobic drugs for oral-delivery preparations.
No full text is available. To read the body of this article, please view the PDF online.
aRussell Berrie Nanotechnology Institute, Technion, Israel Institute of Technology, Haifa 32000, Israel
bLaboratory of Biopolymers and Food Nanotechnology, Department of Biotechnology and Food Engineering, Technion, Israel Institute of Technology, Haifa 32000, Israel
cThe Fred Wyszkowski Cancer Research Laboratory, Faculty of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel